Hemophilia advocacy and treatment is a cause close to Chris and Jacob's hearts. Jacob was born with the condition and thus has firsthand experience with its implications. Fortunately, his case is moderate enough that the symptoms will not bar him from completing something of this nature. Chris is passionate and fascinated by genetic disorders such as hemophilia and studies genetics at university. Together, Chris and Jacob would like to bring their community's attention toward the condition, in hopes of alleviating the limitations the disorder puts on patients' lives.
When successful, the pair will be the youngest team to complete the row across the Pacific (E-W from California to Hawaii), and Jacob will be the first hemophiliac to have completed an ocean row.
Hemophilia is a rare blood disorder that inhibits the blood from clotting normally. Blood clots considerably slower for a hemophiliac than a person without the condition, which can be life-threatening- especially following injuries to vital areas such as the head, kidneys, or major muscles. Hemophilia is a unique disorder in that more severe cases account for 60% of the population. These cases often require frequent emergency care and preventative treatment known as prophylaxis. Hemophilia of Georgia estimates "A common type of bleeding, into a joint, can cost $200 to $6,000 to treat one time, depending on the person's weight. A person with hemophilia may spend $40,000 to over $200,000 each year for his medical care."